nafamostat has been researched along with lactic acid in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arakawa, K; Ideishi, M; Kinoshita, A; Miura, S; Motoyama, M; Sakai, T; Sasaguri, M; Shindo, M; Tanaka, H | 1 |
Noda, Y; Yin, J; Yotsuyanagi, T | 1 |
Choo, SJ; Chung, CH; Jung, SH; Kim, JB; Lee, JW; Park, SJ | 1 |
1 trial(s) available for nafamostat and lactic acid
Article | Year |
---|---|
Angiotensin II formation by an alternative pathway during exercise in humans.
Topics: Adult; Angiotensin I; Angiotensin II; Benzamidines; Blood Pressure; Bradykinin; Captopril; Cross-Over Studies; Double-Blind Method; Exercise; Guanidines; Heart Rate; Humans; Lactates; Lactic Acid; Male; Peptidyl-Dipeptidase A; Renin; Serine Proteinase Inhibitors | 1994 |
2 other study(ies) available for nafamostat and lactic acid
Article | Year |
---|---|
Properties of poly(lactic-co-glycolic acid) nanospheres containing protease inhibitors: camostat mesilate and nafamostat mesilate.
Topics: Benzamidines; Chemistry, Pharmaceutical; Esters; Gabexate; Guanidines; Lactic Acid; Molecular Weight; Nanotubes; Particle Size; Peptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymers; Protease Inhibitors; Solubility | 2006 |
Outcomes of extracorporeal life support for low cardiac output syndrome after major cardiac surgery.
Topics: Adult; Aged; Anticoagulants; Area Under Curve; Benzamidines; Biomarkers; Cardiac Output, Low; Cardiac Surgical Procedures; Chi-Square Distribution; Extracorporeal Circulation; Female; Guanidines; Heart Transplantation; Heparin; Humans; Lactic Acid; Logistic Models; Male; Middle Aged; Multivariate Analysis; Reoperation; Retrospective Studies; Risk Factors; ROC Curve; Time Factors; Treatment Outcome | 2014 |